Physician profile
Malcolm W Mackenzie
NPI 1578650610
$11,073.09
in general payments reported to CMS, 2019-2025
8 companies · $1,125 in 2025
The $1,125 reported for 2025 was more than what 91% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28.76 · 2020: $4,515 · 2021: $2,884 · 2022: $1,005 · 2023: $443 · 2024: $1,072 · 2025: $1,125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,175 · Food and Beverage: $465.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,175.00 |
| Food and Beverage | $465.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Winter & Ibe Gmbh | $4,515.00 | 2020-2021 | |
| Coopersurgical, INC. | $2,736.56 | 2021-2025 | |
| Gyrus Acmi, INC. | $2,035.00 | 2020 | |
| Olympus Corporation of The Americas | $1,138.76 | 2019-2022 | |
| Intuitive Surgical, INC. | $359.03 | 2021-2023 | Da Vinci Surgical System |
| Coloplast Corp | $155.97 | 2023 | Altis |
| Boston Scientific Corporation | $94.43 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $38.34 | 2023-2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Malcolm Mackenzie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.